Dapirolizumab Pegol

dapirolizumab pegol · UCB Biopharma SRL

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Dapirolizumab Pegol, covering 2021-06-30 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus [Phase 3]

See pricing